Indiana University School of Medicine, Indianapolis, IN, USA.
Regenstrief Institute, Indianapolis, IN, USA.
Inquiry. 2024 Jan-Dec;61:469580241284168. doi: 10.1177/00469580241284168.
The availability of direct-to-consumer, at-home medical tests has grown over the last decade, but it is unknown how frequently older adults purchase at-home tests, how they perceive such tests, and how interested they are in using at-home tests in the future. We conducted a cross-sectional, nationally representative survey of non-institutionalized US adults aged 50 to 80 about their previous use of, perceptions of, and future intentions to use at-home medical tests. We found that nearly half of older adults (48.1%) have purchased an at-home medical test (95% CI 45.2%-51.0%), including 32.0% (95% CI 29.3%-34.8%) who purchased a COVID-19 test, 16.6% (95% CI 14.7%-18.7%) who purchased an at-home DNA or genetic test, 5.6% (95% CI 4.5%-7.0%) who purchased a screening test for cancer, and 4.4% (95% CI 3.4%-5.6%) who purchased a test for an infection other than COVID-19. Compared with White, non-Hispanic adults, Black, non-Hispanic adults were less likely to have purchased an at-home test (35.5% vs 49.6%, < .01). Those with a college degree and those with an annual household income greater than $100K were more likely than others to have purchased at-home tests (55.5% vs 42.0%, < .01; 60.6% vs 39.0%, < .001, respectively). Most older adults had positive perceptions about at-home tests and expressed interest in using at-home tests in the future. At-home medical testing is now common among older adults. Clinicians should be familiar with different tests that patients can purchase and be prepared to discuss the potential advantages and disadvantages of at-home testing.
在过去的十年中,直接面向消费者的家庭医疗检测产品越来越多,但我们尚不清楚老年人购买家庭检测产品的频率、他们对这些检测产品的看法,以及他们对未来使用家庭检测产品的兴趣。我们对年龄在 50 至 80 岁之间的、非机构化的美国成年人进行了一项横断面、全国代表性调查,以了解他们之前使用家庭医疗检测产品的情况、对这些产品的看法,以及他们未来使用这些产品的意愿。我们发现,近一半的老年人(48.1%)购买过家庭医疗检测产品(95%CI:45.2%-51.0%),其中 32.0%(95%CI:29.3%-34.8%)购买过 COVID-19 检测产品,16.6%(95%CI:14.7%-18.7%)购买过家庭 DNA 或基因检测产品,5.6%(95%CI:4.5%-7.0%)购买过癌症筛查检测产品,4.4%(95%CI:3.4%-5.6%)购买过除 COVID-19 以外的感染检测产品。与白人非西班牙裔成年人相比,黑人非西班牙裔成年人购买家庭检测产品的可能性较小(35.5%比 49.6%,<0.01)。拥有大学学历和年收入超过 10 万美元的人比其他人更有可能购买家庭检测产品(55.5%比 42.0%,<0.01;60.6%比 39.0%,<0.001)。大多数老年人对家庭检测产品持有积极的看法,并表示有兴趣在未来使用家庭检测产品。家庭医疗检测目前在老年人中很常见。临床医生应该熟悉患者可以购买的不同检测产品,并准备好讨论家庭检测的潜在优势和劣势。